Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
Seenu M Hariprasad1, Levent Akduman2, Joseph A Clever2, Michael Ober3,4, Franco M Recchia5, William F Mieler1,61Department of Ophthalmology and Visual Sciences, Vitreoretinal Service; 6Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, IL, USA; 2Vitreoretinal Service, S...
Main Authors: | Seenu M Hariprasad, Levent Akduman, Joseph A Clever, Michael Ober, Franco M Recchia, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-01-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/treatment-of-cystoid-macular-edema-with-the-new-generation-nsaid-nepaf-a2800 |
Similar Items
-
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
by: Giarmoukakis AK, et al.
Published: (2020-11-01) -
Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
by: Alexander Aaronson, et al.
Published: (2020-09-01) -
Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema
by: Asena Keleş Şahin, et al.
Published: (2020-12-01) -
Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac
by: Sabyasachi Sengupta, et al.
Published: (2018-01-01) -
Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification
by: Ana María Chinchurreta Capote, et al.
Published: (2018-07-01)